|Reference : Importance of Cell Kinetics Rhythmicity for the Control of Cell Proliferation and Carcin...|
|Scientific journals : Article|
|Life sciences : Genetics & genetic processes|
|Importance of Cell Kinetics Rhythmicity for the Control of Cell Proliferation and Carcinogenesis in Rat Liver (Review)|
|Barbason, Hervé [Université de Liège - ULg > > Relations académiques et scientifiques (Médecine) >]|
|Herens, Christian [Centre Hospitalier Universitaire de Liège - CHU > > PLAN COS >]|
|Robaye, B. [> > > >]|
|Milis, G. [> > > >]|
|Sulon, Joseph [Université de Liège - ULg > Département de sciences fonctionnelles > Physiologie de la reproduction >]|
|Bouzahzah, B. [> > > >]|
|Van Cantfort, Jacques [Centre Hospitalier Universitaire de Liège - CHU > > Pharmacologie clinique >]|
|In Vivo (Athens, Greece)|
|[en] The circadian control of cell Proliferation and Differentiation has been studied principally in rat liver. The comparison between the differentiation by hepatic enzymes and the division by the cell cycle under various experimental conditions (postnatal maturation, regeneration after partial hepatectomy, adrenalectomy, corticosterone treatments etc.) leads to the following conclusions: Under physiological conditions, proliferation and differentiation activities present a mutually exclusive relationship with a specific circadian rhythm. For both functions, the circadian variation of corticosterone plays the role of synchronizer, each evening (peak) it induces the synthesis of tissue specific enzymes in G0 cells and simultaneously inhibits the DNA synthesis in cycling cells. The same parameters have been studied during the different stages of hepatocarcinogenesis induced by Diethylnitrosamine (DEN). After initiation alone, (DEN for 2 weeks) circadian control is unchanged and precancerous cells are not able to reach malignancy. Promotion (DEN for 6 weeks) consists of disturbing the circadian synchronization to liberate the selective growth of initiated precancerous cells. This proliferation advantage favours the accumulation of chromosomal aberrations including those implicated in malignant transformation: i.e. activation of oncogenes or inhibition of antioncogenes.|
There is no file associated with this reference.
All documents in ORBi are protected by a user license.